title: Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).
abstract: BACKGROUND
  Chronic right ventricular pacing has been reported to promote cardiac dyssynchrony. The PAVE trial prospectively compared chronic biventricular pacing to right ventricular pacing in patients undergoing ablation of the AV node for management of atrial fibrillation with rapid ventricular rates.
  
  
  RESULTS
  One hundred and eighty-four patients requiring AV node ablation were randomized to receive a biventricular pacing system (n = 103) or a right ventricular pacing system (n = 81). The study endpoints were change in the 6-minute hallway walk test, quality of life, and left ventricular ejection fraction. Patient characteristics were similar (64% male; age: 69 +/- 10 years, ejection fraction: 0.46 +/- 0.16; 83%, NYHA Class II or III). At 6 months postablation, patients treated with cardiac resynchronization had a significant improvement in 6-minute walk distance, (31%) above baseline (82.9 +/- 94.7 m), compared to patients receiving right ventricular pacing, (24%) above baseline (61.2 +/- 90.0 m) (P = 0.04). There were no significant differences in the quality-of-life parameters. At 6 months postablation, the ejection fraction in the biventricular group (0.46 +/- 0.13) was significantly greater in comparison to patients receiving right ventricular pacing (0.41 +/- 0.13, P = 0.03). Patients with an ejection fraction <or=45% or with NYHA Class II/III symptoms receiving a biventricular pacemaker appear to have a greater improvement in 6-minute walk distance compared to patients with normal systolic function or Class I symptoms.
  
  
  CONCLUSIONS
  For patients undergoing AV node ablation for atrial fibrillation, biventricular pacing provides a significant improvement in the 6-minute hallway walk test and ejection fraction compared to right ventricular pacing. These beneficial effects of cardiac resynchronization appear to be greater in patients with impaired systolic function or with symptomatic heart failure.
authors.affiliation: Cardiovascular Consultants of Nevada, Las Vegas, Nevada 89074, USA. rdoshi@earthlink.net
authors.forename: Rahul N
authors.initials: RN
authors.lastname: Doshi
authors.forename: Emile G
authors.initials: EG
authors.lastname: Daoud
authors.forename: Christopher
authors.initials: C
authors.lastname: Fellows
authors.forename: Kyong
authors.initials: K
authors.lastname: Turk
authors.forename: Aurelio
authors.initials: A
authors.lastname: Duran
authors.forename: Mohamed H
authors.initials: MH
authors.lastname: Hamdan
authors.forename: Luis A
authors.initials: LA
authors.lastname: Pires
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000628:therapy*; D001283:Atrioventricular Node / Q000601:surgery*; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D017115:Catheter Ablation / Q000379:methods*; D016009:Chi-Square Distribution; D003131:Combined Modality Therapy; D005260:Female; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D018709:Statistics, Nonparametric; D013318:Stroke Volume; D016896:Treatment Outcome